AMGN Amgen Inc.Financial Income Statement
$300.240.75 (+0.25%)1:07 PM 05/07/24
NASDAQ | $USD | Realtime
AMGN Income Statement
Period
View
Order
Currency
Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | ||||||||||||
| Revenues | 22,204.0 | 24,240.0 | 24,297.0 | 24,801.0 | 26,910.0 | 28,182.0 | ||||||
| Other Revenues | 1,158.0 | 1,184.0 | 1,682.0 | 1,522.0 | 1,280.0 | 1,350.0 | ||||||
| Total Revenues | 23,362.0 | 25,424.0 | 25,979.0 | 26,323.0 | 28,190.0 | 29,532.0 | ||||||
| Cost Of Revenues | 4,356.0 | 6,159.0 | 6,454.0 | 6,406.0 | 8,415.0 | 9,895.0 | ||||||
| Gross Profit | 19,006.0 | 19,265.0 | 19,525.0 | 19,917.0 | 19,775.0 | 19,637.0 | ||||||
Operating Expenses & Income | ||||||||||||
| Selling General & Admin Expenses | 5,150.0 | 5,730.0 | 5,368.0 | 5,414.0 | 6,166.0 | 6,716.0 | ||||||
| R&D Expenses | 4,116.0 | 4,207.0 | 4,819.0 | 4,434.0 | 4,755.0 | 5,040.0 | ||||||
| Other Operating Expense/(Income) | - | - | 194.0 | - | 690.0 | 650.0 | ||||||
| Total Operating Expenses | 9,266.0 | 9,937.0 | 10,381.0 | 9,848.0 | 11,611.0 | 12,406.0 | ||||||
| Operating Income | 9,740.0 | 9,328.0 | 9,144.0 | 10,069.0 | 8,164.0 | 7,231.0 | ||||||
Earnings from Continuing Operations | ||||||||||||
| Interest Expense | (1,289.0) | (998.0) | (1,197.0) | (1,406.0) | (2,875.0) | (3,156.0) | ||||||
| Interest And Investment Income | - | - | - | - | - | - | ||||||
| Net Interest Expenses | (1,289.0) | (998.0) | (1,197.0) | (1,406.0) | (2,875.0) | (3,156.0) | ||||||
| Currency Exchange Gains (Loss) | 110.0 | 323.0 | (245.0) | (233.0) | 42.0 | 33.0 | ||||||
| Other Non Operating Income (Expenses) | 587.0 | (26.0) | 978.0 | (180.0) | 1,128.0 | 1,122.0 | ||||||
| EBT, Incl. Unusual Items | 9,138.0 | 8,133.0 | 6,701.0 | 7,346.0 | 7,855.0 | 4,345.0 | ||||||
| Income Tax Expense | 1,296.0 | 869.0 | 808.0 | 794.0 | 1,138.0 | 582.0 | ||||||
| Earnings From Continuing Operations | 7,842.0 | 7,264.0 | 5,893.0 | 6,552.0 | 6,717.0 | 3,763.0 | ||||||
Net Income | ||||||||||||
| Net Income to Company | 7,842.0 | 7,264.0 | 5,893.0 | 6,552.0 | 6,717.0 | 3,763.0 | ||||||
| Net Income | 7,842.0 | 7,264.0 | 5,893.0 | 6,552.0 | 6,717.0 | 3,763.0 | ||||||
| NI to Common Incl Extra Items | 7,842.0 | 7,264.0 | 5,893.0 | 6,552.0 | 6,717.0 | 3,763.0 | ||||||
| NI to Common Excl. Extra Items | 7,842.0 | 7,264.0 | 5,893.0 | 6,552.0 | 6,717.0 | 3,763.0 | ||||||
Supplemental Items | ||||||||||||
| Revenue Per Share | $38.61 | $43.39 | $45.58 | $48.93 | $52.69 | $55.15 | ||||||
| Basic EPS | $12.96 | $12.40 | $10.34 | $12.18 | $12.56 | $7.03 | ||||||
| Basic EPS - Continuing Ops | $12.96 | $12.40 | $10.34 | $12.18 | $12.56 | $7.03 | ||||||
| Basic Weighted Average Shares Outst. | 605.0 | 586.0 | 570.0 | 538.0 | 535.0 | 535.5 | ||||||
| Diluted EPS | $12.88 | $12.31 | $10.28 | $12.11 | $12.49 | $7.01 | ||||||
| Diluted EPS - Continuing Ops | $12.88 | $12.31 | $10.28 | $12.11 | $12.49 | $7.01 | ||||||
| Diluted Weighted Average Shares Outst. | 609.0 | 590.0 | 573.0 | 541.0 | 538.0 | 537.5 | ||||||
| Normalized Basic EPS | $9.45 | $9.20 | $9.52 | $9.58 | $7.55 | $6.11 | ||||||
| Normalized Diluted EPS | $9.39 | $9.14 | $9.47 | $9.53 | $7.50 | $6.09 | ||||||
| Dividend Per Share | $5.80 | $6.40 | $7.04 | $7.76 | $8.52 | $8.64 | ||||||
| Payout Ratio | 44.75% | 51.69% | 68.10% | 64.04% | 67.83% | 122.96% | ||||||
| EBITDA | 11,775.0 | 12,929.0 | 12,542.0 | 13,486.0 | 12,235.0 | 11,801.0 | ||||||
| EBITA | 11,140.0 | 12,128.0 | 11,744.0 | 12,669.0 | 11,364.0 | 10,938.0 | ||||||
| EBIT | 9,740.0 | 9,328.0 | 9,144.0 | 10,069.0 | 8,164.0 | 7,231.0 | ||||||
| EBITDAR | 11,946.0 | 13,118.0 | 12,741.0 | 13,672.0 | 12,415.0 | - | ||||||
| Effective Tax Rate | 14.2% | 10.7% | 12.1% | 10.8% | 14.5% | 13.4% | ||||||
| Normalized Net Income | 5,717.5 | 5,391.9 | 5,425.0 | 5,156.3 | 4,036.9 | 3,273.1 | ||||||
| Interest Capitalized | - | - | - | - | - | - | ||||||
| Interest on Long-Term Debt | - | - | - | - | - | - | ||||||
| R&D Expense From Footnotes | 4,116.0 | 4,207.0 | 6,324.0 | 4,434.0 | 4,784.0 | 5,069.0 | ||||||
| Foreign Sales | 6,138.0 | 6,928.0 | 7,785.0 | 7,728.0 | 8,384.0 | - | ||||||
In Millions of United States Dollar (USD) except per share items